Kristi Rosa

Health officials are in the process of investigating a mumps outbreak that has sprung up among attendees of Mexican dance events in Delaware.

Three multistate Salmonella outbreaks are hitting the United States—here's what you should know about them.

Here’s what needs to be addressed in order to make real progress in the fight against antimicrobial resistance, according to Dr. Ramanan Laxminarayan, PhD, Center for Disease Dynamics, Economics, & Policy.

A new study from Johns Hopkins School of Medicine highlights major racial & ethnic disparities in the diagnosis and treatment of trichomoniasis in the United States.

This comes on the heels of 2 recent FDA approvals of 2 Mylan antiretrovirals: Cimduo and Symfi Lo.

Culture-independent diagnostic tests offer better food-borne infection incidence estimates, but without isolates, laboratories are unable to subtype pathogens, determine antimicrobial susceptibility, and detect outbreaks.

A recent study explores the use of isavuconazole for prophylaxis against invasive fungal infections in allogeneic stem cell transplant patients.

Preliminary research suggests that women who take antibiotics for long periods of time in late adulthood may be at increased risk of death from heart disease and other causes.

In light of World TB Day, the CDC has released provisional TB surveillance data indicating a decline in cases in the United States, but at a rate that’s too slow to achieve elimination in this century.

A new study suggests that an antiretroviral combination of dolutegravir with darunavir/cobicistat can be prescribed safely in the treatment of HIV-1.

AIDS researcher Robert Redfield, MD, has officially been named the new director of the CDC.

The CDC has announced that they are investigating yet another multistate outbreak of Salmonella, this time, linked to dried coconut product.

The number of individuals infected with Listeria continues to grow in South Africa, as officials identify the source responsible.

D/C/F/TAF achieved high virologic response rates that were overall noninferior to the control D/C+F/TDF, as well as favorable bone and renal outcomes that were consistent across age, gender, and race subgroups in phase 3 AMBER trial.

All doses of MK-8591 were generally well-tolerated with a limited number of reported mild/moderate adverse events.

The New Jersey Department of Health has issued a public health alert warning of another potential measles exposure at Newark International Airport.

Scientists from the NIH and Rutgers New Jersey Medical School are in the process of developing a promising alternative to antibiotic treatments for multidrug-resistant Klebsiella pneumoniae bacteria.

Hair levels are found to be the strongest independent predictor of virologic success in a recent treatment trial.

Raltegravir-intensified therapy resulted in significantly faster viral load declines in HIV-infected adults and older children but did not reduce overall mortality or WHO 3/4 events compared with standard triple-drug ART.

At CROI 2018, Dr. Linda-Gail Bekker highlighted 7 controversies surrounding PrEP and provided conference attendees with enough evidence to separate fact from fiction.

One study takes a look at how out-of-pocket costs impede the use of pre-exposure prophylaxis in young men who have sex with men.

Dr. Meg Watson from the CDC reports updated information regarding the current rates and trends of HIV diagnoses in the South at 2018 CROI.

At CROI 2018, Dr. Helen Weiss highlighted where we are in terms of meeting these goals, where the challenges are, and strategies to help prevent new infections.

Flu activity is down for the second week in a row in the United States, but as the flu season still has several weeks to go, the FDA has issued a warning about counterfeit flu medications.

In an oral abstract session at CROI 2018, Dr. Nathan Thielman stresses that understanding the interest of HIV-positive treatment-experienced individuals in new antiretroviral therapies may help inform their development and uptake.

Better understanding of the vaginal microbiome may provide new insights into HIV acquisition.

First detailed analysis by race and risk group finds that two-thirds of those who could benefit from PrEP are African American or Latino, but they account for the smallest percentage of prescriptions to date.

Week 48 safety results show that switching to B/F/TAF was noninferior to remaining on DTG/ABC/3TC.

Better understanding of the pathogenesis of tuberculosis can help inform the development of a new, effective vaccine.

Week 24 safety and efficacy data on women who switched from a baseline regimen (SBR) to B/F/TAF were presented at CROI 2018.